Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience

• Egile Nagusiak: Dana M. Chase (Egilea), Laura Iadeluca (Egilea), Jonathan Lim (Egilea), Wan-Yu Tseng (Egilea), Purva Bulsara (Egilea), Gregory Patton (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective: Previous studies have shown that first-line (1L) maintenance therapy (MT) with poly(ADP-ribose) polymerase inhibitors and/or bevacizumab improves outcomes among patients with advanced ovarian cancer (OC); however, these treatments are underutilized. This study aimed to provide a real-worl...